Published

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Biological psychiatry
Date: 2015-10-15
Source: PubMed
DOI: 10.1016/j.biopsych.2014.04.010
PubMed: 24882567

Authors

Kraehenmann R Preller KH Scheidegger M Pokorny T Bosch OG Seifritz E Vollenweider FX

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Brain Imaging Receptor Pharmacology Aging Emotional Processing Healthy Volunteers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms2026-07-01 Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.2015-10-15

Related papers

No close related records were found yet.